Pipeline

Overview

Ocera’s pipeline consists of two compounds targeting acute and chronic liver disease as well as various gastrointestinal disorders.

	Pre-clinical	Phase 1	Phase 2	Phase 3
Mild Hepatic Encephalopathy
AST-120
Irritable Bowel Syndrome (non constipating)
AST-120
Pouchitis
AST-120
Acute Hepatic Encephalopathy in Liver Cirrhosis
OCR-002
Acute Hepatic Encephalopathy in Acute Liver Failure
OCR-002